Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Pharmacotherapy ; 26(5): 713-8, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16718946

RESUMEN

Nitrofurantoin may be used for prophylaxis of recurrent urinary tract infections in women; however, this agent has been associated with acute, subacute, and chronic pulmonary adverse reactions. The acute reaction occurs in about 1/5,000 women after their first exposure to the drug. We report the occurrence of two successive, highly probable (by Naranjo score) nitrofurantoin-induced acute pulmonary reactions in the same patient. On day 4 of prophylaxis with nitrofurantoin 100 mg/day (to prevent urinary tract infections), the patient developed intense substernal pain and pressure. On day 8, she experienced intense substernal burning. She went to the emergency department, where she vomited and was hypotensive and febrile. Her chest radiograph showed bilateral infiltrates. The patient was diagnosed with pneumonia and was prescribed levofloxacin; she stopped taking the nitrofurantoin. Her symptoms subsided over the next 3 days. Ten days later, the patient restarted the nitrofurantoin, and she returned to the emergency department after again experiencing sudden intense substernal burning, nausea, vomiting, shivering, and weakness. Nitrofurantoin was discontinued; her symptoms resolved quickly, and prophylaxis with trimethoprim-sulfamethoxazole was begun. After 1 year, the patient had experienced no further pulmonary symptoms or urinary tract infections. Drug toxicity must be considered in patients who develop pulmonary symptoms while taking nitrofurantoin. Symptoms are often misdiagnosed as other ailments, potentially subjecting patients to unnecessary treatments and delaying discontinuation of nitrofurantoin. Patients should be advised to contact a physician if breathing difficulties or unusual symptoms develop while taking nitrofurantoin, as this could result in earlier recognition of this drug reaction.


Asunto(s)
Antiinfecciosos Urinarios/efectos adversos , Enfermedades Pulmonares/inducido químicamente , Nitrofurantoína/efectos adversos , Hipersensibilidad a las Drogas/fisiopatología , Femenino , Humanos , Persona de Mediana Edad , Recurrencia , Infecciones Urinarias/prevención & control
2.
Opt Lett ; 31(7): 1008-10, 2006 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-16599239

RESUMEN

We propose and demonstrate a novel implementation of spectral-shearing interferometry (SSI) for reconstructing the electric field of ultrashort pulses by utilizing asymmetric group velocity matching in a long nonlinear crystal. The proposed configuration eliminates the requirement for a linearly chirped auxiliary pulse that is in common in all existing SSI methods, relying on nonlinear conversion to produce a spectral shear.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA